NCNMGF
JANX icon

Nano-Cap New Millennium Growth Fund’s Janux Therapeutics JANX Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$860K Buy
56,000
+16,500
+42% +$239K 0.66% 58
2026
Q1 		$549K Buy
39,500
+37,000
+1,480% +$507K 0.51% 72
2025
Q4 		$34.5K Buy
+2,500
New +$58.8K 0.03% 165

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's JANX Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund increased its Janux Therapeutics (JANX) stake by 42% in Q2 2026, buying an estimated $239K and bringing the position to 56,000 shares worth $860K. The position accounts for 0.66% of the portfolio, ranked #58.

Nano-Cap New Millennium Growth Fund first reported a position in JANX in Q4 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 56,000 shares of Janux Therapeutics worth $860K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund bought 16,500 Janux Therapeutics shares in Q2 2026, an estimated $239K.
  • Janux Therapeutics made up 0.66% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #58 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Janux Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.